PM3 USE OF PHARMACOGENETIC TESTING TO DETERMINE ADJUVANT HORMONAL THERAPY CHOICE IN EARLY STAGE BREAST CANCER PATIENTS- A VALUE OF INFORMATION ANALYSIS
May 1, 2009, 00:00
10.1016/S1098-3015(10)73082-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)73082-5/fulltext
Title :
PM3 USE OF PHARMACOGENETIC TESTING TO DETERMINE ADJUVANT HORMONAL THERAPY CHOICE IN EARLY STAGE BREAST CANCER PATIENTS- A VALUE OF INFORMATION ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73082-5&doi=10.1016/S1098-3015(10)73082-5
First page :
Section Title :
Open access? :
No
Section Order :
679